Project Grant R01EB039955
- The National Institute of Biomedical Imaging and Bioengineering awarded The Leland Stanford Junior University $217,500 on April 10, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop portable resonance gradient coils for faster MRI with simplified calibration and real-time image reconstruction. The project addresses limitations in MRI encoding speed that constrain exam duration, scheduling availability, and...
- This $1,199,991 Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program aims to develop novel technologies for real-time assessment of blood clot properties to improve stroke treatment. The key products and services under this grant include: Integration of a sub-millimeter Raman fiber probe into a catheter for intravascular, in-vivo measurement of clot chemical composition. Training of a convolutional neural network to...
- The National Institute of Biomedical Imaging and Bioengineering awarded The Leland Stanford Junior University $428,089 on April 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop protein-based conductive, injectable, biodegradable hydrogels for cell-based tissue regeneration. Stanford will design and synthesize a recombinant hydrogel incorporating electrically conductive protein nanowires, an engineered...
- The National Institute of Biomedical Imaging and Bioengineering awarded The Trustees Of The Stevens Institute Of Technology $185,998 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a steerable micro-guidewire powered by piezoelectric actuation for minimally invasive stroke treatment. The project develops a novel guidewire incorporating a piezoelectric helical actuator capable of active...
- The National Institute of Biomedical Imaging and Bioengineering awarded The Leland Stanford Junior University $192,500 for the development and testing of an ingestible robotic device capable of collecting visceral samples from the gastrointestinal tract on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award funds development of a programmable, swallowable robotic pill (RoboPill) designed to perform...
- The National Institute of Neurological Disorders and Stroke awarded The Leland Stanford Junior University $499,516 on February 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (NINDS, CFDA 93.853) to develop a novel imaging strategy for optimizing brain tumor immunotherapy. The recipient will develop a first-in-class small molecule positron emission tomography (PET) probe capable of crossing the blood-brain barrier and binding to perforin, a...
- The National Institute of Neurological Disorders and Stroke awarded The Leland Stanford Junior University $154,274 on May 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop small-focus transparent transducers for transcranial ultrasound stimulation in mice. The research addresses the absence of noninvasive tools for focal brain-wide neuromodulation, a limitation that constrains circuit-based understanding of neural...
- The National Heart, Lung, and Blood Institute awarded The Leland Stanford Junior University $767,249 on June 22, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and validate computational models for designing organ-scale vasculature in biomanufactured cardiac tissues. The project addresses the need for patient-specific engineered tissues to repair complex congenital heart defects, particularly large ventricular septal defects where current surgical approaches...
- The National Institute of Biomedical Imaging and Bioengineering awarded Georgia TECH Research Corp $625,554 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a robotically-delivered therapeutic ultrasound system for safe, effective treatment of large vessel occlusive stroke. The project addresses the clinical challenge that 75 percent of large vessel occlusive stroke patients fail on first-attempt...
- The National Institute of General Medical Sciences, part of the Department of Health and Human Services National Institutes of Health, awarded The Leland Stanford Junior University $1,733,072 on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop a multi-resolution open-top light-sheet expansion microscopy system. The project will advance 3D microscopy for high-throughput imaging of expanded tissues with ultra-high resolution—sub-150 nanometer...
The National Institute of Biomedical Imaging and Bioengineering awarded The Leland Stanford Junior University $2,421,019 on August 5, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to optimize milli-spinner thrombectomy technology for acute ischemic stroke treatment. The funded work addresses the failure of current thrombectomy devices (aspiration and stent-retrievers) in approximately 15 percent of acute ischemic stroke patients and their achievement of first-pass clot removal in fewer than 50 percent of cases. The recipient will conduct three integrated aims: mechanistic studies using in-vitro experiments and computational simulations to quantify clot microstructure response under spinner-induced mechanical loading; optimization of spinner design and operating parameters through a surrogate-model-guided framework integrating experimental and simulation data; and in-vivo validation in animal models to confirm optimized performance. The milli-spinner technology employs controlled microstructure densification to shrink and debulk clots, enabling faster and more complete removal compared to aspiration devices alone. Performance will occur in Palo Alto, California through August 4, 2030. This is a Project Grant assistance type supporting hypothesis- and device-driven research in biomedical imaging and bioengineering technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.8m | 8/11/26 | ||
| Not listed | $637.2k | 8/3/26 |